Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3277547

Documents

Beta release

Statistics of Anti-GD2 based immunotherapy prevents late events in high-risk neuroblastoma patients over 18 months at diagnosis
Statistics for this year
PeriodVisitsDownloads
2024109
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0811
2024-0922
2024-1032